Liangjiang Medicine is a new R&D organization with innovative drugs and modified new drugs as the core of R&D.
Liangjiang Medicine’s innovative cancer topical application program will use preparation technology and pre-drug technology to solve the problems of existing topical application preparations or to create unique topical application preparation products to bring better treatment options for patients with early and locally advanced tumors.The Company’s R&D team currently consists of more than 10 core members, including 4 overseas PhDs, and the management team are all senior experts with more than 20 years of experience in new drug development.